Driven by ambition, integrity, innovation and passion with a resolute focus to deliver value to the business, patients and society.
Experienced in gastrointestinal and respiratory diseases, blood and growth disorders, gastroenterology, rheumatology, dermatology, antivirals and antibiotics.
Highly experienced in: working with EMA, FDA, PMDA and other national agencies, strategic planning, cross-functional team leadership and major change management projects such as mergers, separation of two companies and re-structuring of global and regional functions.
Strong knowledge base on: Business Operations, Corporate Legal & Strategy, Corporate Finance, Quality & Compliance, Business Development & Alliance Management.
María se ha incorporado a PharmaMar procedente de Novo Nordisk A/S, donde ocupó el cargo de Corporate Global Vice President and Head of Biopharm Global Regulatory Affairs.
Antes de incorporarse a Novo Nordisk, María ocupó varios puestos directivos en GE Healthcare, GSK, Abbott, Takeda y Norgine.
María es doctora en Bioquímica por el King's College de la Universidad de Londres, tiene una licenciatura en Farmacia con Postgrado en Toxicología por la Universidad de Valencia. También tiene un Diploma de Postgrado en Asuntos Regulatorios de la Universidad de Cardiff.